BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15235064)

  • 1. Neuroblastoma: a disease requiring a multitude of imaging studies.
    Kushner BH
    J Nucl Med; 2004 Jul; 45(7):1172-88. PubMed ID: 15235064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroblastoma].
    Simon T
    Urologe A; 2005 May; 44(5):543-54; 555. PubMed ID: 15856156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
    El-Maghraby T
    Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
    Matthay KK; Edeline V; Lumbroso J; Tanguy ML; Asselain B; Zucker JM; Valteau-Couanet D; Hartmann O; Michon J
    J Clin Oncol; 2003 Jul; 21(13):2486-91. PubMed ID: 12829667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].
    Défachelles AS; Cougnenc O; Carpentier P
    Bull Cancer; 2011 May; 98(5):559-69. PubMed ID: 21609890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
    Hero B; Hunneman DH; Gahr M; Berthold F
    Med Pediatr Oncol; 2001 Jan; 36(1):220-3. PubMed ID: 11464889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroblastoma and other neuroendocrine tumors.
    Howman-Giles R; Shaw PJ; Uren RF; Chung DK
    Semin Nucl Med; 2007 Jul; 37(4):286-302. PubMed ID: 17544628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten challenges in the management of neuroblastoma.
    Gains J; Mandeville H; Cork N; Brock P; Gaze M
    Future Oncol; 2012 Jul; 8(7):839-58. PubMed ID: 22830404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
    Kushner BH; Yeh SD; Kramer K; Larson SM; Cheung NK
    J Clin Oncol; 2003 Mar; 21(6):1082-6. PubMed ID: 12637474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.
    Boubaker A; Bischof Delaloye A
    Q J Nucl Med; 2003 Mar; 47(1):31-40. PubMed ID: 12714952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.
    Matthay KK; Brisse H; Couanet D; Couturier J; Bénard J; Mosseri V; Edeline V; Lumbroso J; Valteau-Couanet D; Michon J
    Cancer; 2003 Jul; 98(1):155-65. PubMed ID: 12833468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation.
    Lonergan GJ; Schwab CM; Suarez ES; Carlson CL
    Radiographics; 2002; 22(4):911-34. PubMed ID: 12110723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroblastoma: biology, prognosis, and treatment.
    Park JR; Eggert A; Caron H
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):65-86. PubMed ID: 20113896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma: biology, prognosis, and treatment.
    Park JR; Eggert A; Caron H
    Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated imaging using MRI and 123I metaiodobenzylguanidine scintigraphy to improve sensitivity and specificity in the diagnosis of pediatric neuroblastoma.
    Pfluger T; Schmied C; Porn U; Leinsinger G; Vollmar C; Dresel S; Schmid I; Hahn K
    AJR Am J Roentgenol; 2003 Oct; 181(4):1115-24. PubMed ID: 14500242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies.
    Newman EA; Nuchtern JG
    Semin Pediatr Surg; 2016 Oct; 25(5):257-264. PubMed ID: 27955728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
    Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
    J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma.
    Katzenstein HM; Cohn SL; Shore RM; Bardo DM; Haut PR; Olszewski M; Schmoldt J; Liu D; Rademaker AW; Kletzel M
    J Clin Oncol; 2004 Oct; 22(19):3909-15. PubMed ID: 15459212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.